SoGAT XVI, Langen 3 rd July 2003
description
Transcript of SoGAT XVI, Langen 3 rd July 2003
Ro / BSD HessenInstitut für Transfusionsmedizin
SoGAT XVI, Langen 3rd July 2003
Immediate Parvo B19 NAT testing of pooled donor samples: logistics and problems
W. Kurt RothRed Cross Blood Transfusion Service Baden-Württemberg – Hessen,
Institute Frankfurt am Main
Ro / BSD HessenInstitut für Transfusionsmedizin
B19 / HAV-PCR: Testing Strategy
B19 and HAV PCR in parallel to HCV, HIV and HBV PCR Aliquots of same extract as for HCV, HIV, HBV Relevant for all blood components incl. platelets Quantitative TaqMan PCR with internal control sequence 95% detection limit: 103 IU / ml (B19 and HAV) B19 positive Pools 105 IU / ml:
– Positive donation identified
– Positive donation destroyed B19 positive Pools < 105IU / ml:
– Positive donation not identified
– All donations released (weak positive)
Ro / BSD HessenInstitut für Transfusionsmedizin
Pool Deconstruction HCV, HBV, HIV, HAV, B19
PCR-only positives PCR and antibody positives
12 x 8
8 x
12
1 x 94
individual testing
Ro / BSD HessenInstitut für Transfusionsmedizin
HAV / Parvo B19-PCR: Results
Positives / Tested Positives / Tested
Virus Pools n / n (%) Donations n / n Rate
HAV 2 / 22 368 (0.009) 2 / 1 832 802 1 : 0.9 Mill
B19 121 / 22 368 (0.54) 162 / 1 832 802 1 : 11 000
April 2000 – May 2003: Sensitivity 105 IU / ml
Rate of B19 positives at a sensitivity of 103 IU / ml: 1 : 700
Ro / BSD HessenInstitut für Transfusionsmedizin
0
2
4
6
8
10
12
14
Parvo B19 Positives per MonthP
ositi
ves
105
(n)
Total
Frankf
West
Ro / BSD HessenInstitut für Transfusionsmedizin
Indications for B19-negative components
Parvo B19-negative (< 103 IU / ml) components upon specific written request; individual label: „Parvovirus B19 not detectable“– Patients with BMT, SCT
– B19 antibody-negative pregant women in the 1.and 2. trimenon
– HIV patients
– Additional risk groups e.g.• transient aplastic crisis • pure red cell aplasia
Parvo B19-negative and weak positive (> 103 ; < 105 IU / ml) components for all patients at no specific risk (no label); standard quality
Ro / BSD HessenInstitut für Transfusionsmedizin
Parvo-B19 Seroconversion
Vorspende Spende Folgespende 2. Folgesp.Datum IgM/
GDatum Konz
ExpIgM IgG Datum Hs-
PCRIgM IgG Wb
NS1IgM Wb
NS104.07.00 - 17.01.01 12 - - 02.08.01 - + ++ +28.03.00 - 14.07.00 12 - - 15.02.01 - ? ++ ++28.02.00 - 20.06.00 11 - - 27.10.00 + ? ++ ? - +15.02.99 15.05.00 11 + - 06.08.00 + + ++ + - ++12.01.00 - 12.04.00 11 - - 05.07.00 + + ++ ? - ?15.01.01 - 16.03.01 8 + - 22.06.01 + - ++ +09.02.00 - 03.05.00 8 - - 09.08.00 + + ++ +30.11.00 - 30.03.01 8 + - 29.06.01 + + ++ +25.08.00 - 27.10.00 7 - - 26.01.01 + + ++ - ? -09.02.00 - 03.05.00 6 + ? 23.08.00 + + ++ ++ + +++19.01.00 - 10.05.00 5 ++ + 17.01.01 - + ++ +++02.04.01 - 02.07.01 5 ++ + 11.09.01 + + ++ +++
Medac IgM and IgG ELISA; Mikrogen IgG/IgM recomBlot